Pramlintide analog of amylin hormone: AMLN began double-blind Phase II testing in Europe to achieve improved control of glucose in 200 patients who are not gett

Fructosamine changes will be used as the primary end point as an

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE